Mark Schonfeld, Founder

Mark Schonfeld founded HELIXIRIN with a clear mission: to bring integrity, innovation, and scientific discipline to the evolving world of hemp and cannabinoids. With a background in law and a personal understanding of how cannabinoids can impact quality of life, Mark combines regulatory insight with a deep commitment to product safety, efficacy, and transparency. His long-term vision extends beyond consumer products—toward advancing research into cannabis genetics and unlocking the therapeutic potential of rare and understudied cannabinoids. Under his leadership, HELIXIRIN is building a future where plant-based compounds meet precision science.